Eden Research plc (EDEN) - Total Assets
Based on the latest financial reports, Eden Research plc (EDEN) holds total assets worth GBX13.46 Million GBX (≈ $1.64K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See EDEN total equity for net asset value and shareholders' equity analysis.
Eden Research plc - Total Assets Trend (2004–2024)
This chart illustrates how Eden Research plc's total assets have evolved over time, based on quarterly financial data.
Eden Research plc - Asset Composition Analysis
Current Asset Composition (December 2024)
Eden Research plc's total assets of GBX13.46 Million consist of 51.3% current assets and 48.7% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 23.9% |
| Accounts Receivable | GBX2.86 Million | 18.6% |
| Inventory | GBX532.65K | 3.5% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX6.89 Million | 44.7% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2004–2024)
This chart illustrates how Eden Research plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Eden Research plc market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Eden Research plc's current assets represent 51.3% of total assets in 2024, an increase from 1.6% in 2004.
- Cash Position: Cash and equivalents constituted 23.9% of total assets in 2024, up from 0.5% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 44.0% of total assets, a decrease from 98.0% in 2004.
- Asset Diversification: The largest asset category is intangible assets at 44.7% of total assets.
Eden Research plc Competitors by Total Assets
Key competitors of Eden Research plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nutrien Ltd
TO:NTR
|
Canada | CA$51.83 Billion |
|
Jiangsu Yangnong Chemical Co Ltd
SHG:600486
|
China | CN¥18.24 Billion |
|
Anhui Huilong Agricultural Means of Production Co Ltd
SHE:002556
|
China | CN¥10.99 Billion |
|
Shandong Sino-Agri United Biotechnology Co Ltd
SHE:003042
|
China | CN¥3.91 Billion |
|
RLF Agtech Ltd
AU:RLF
|
Australia | AU$24.62 Million |
|
Nusa Palapa Gemilang PT Tbk
JK:NPGF
|
Indonesia | Rp317.06 Billion |
|
Highfield Resources Ltd
AU:HFR
|
Australia | AU$187.45 Million |
|
Neurizer Ltd
AU:NRZ
|
Australia | AU$132.63 Million |
Eden Research plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.17 | 3.80 | 9.51 |
| Quick Ratio | 1.90 | 3.53 | 9.20 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX2.82 Million | GBX6.44 Million | GBX9.81 Million |
Eden Research plc - Advanced Valuation Insights
This section examines the relationship between Eden Research plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.86 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -7.2% |
| Total Assets | GBX15.41 Million |
| Market Capitalization | $261.20K USD |
Valuation Analysis
Below Book Valuation: The market values Eden Research plc's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Eden Research plc's assets decreased by 7.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Eden Research plc (2004–2024)
The table below shows the annual total assets of Eden Research plc from 2004 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | GBX15.41 Million ≈ $1.87K |
-7.16% |
| 2023-12-31 | GBX16.59 Million ≈ $2.02K |
+28.53% |
| 2022-12-31 | GBX12.91 Million ≈ $1.57K |
-14.08% |
| 2021-12-31 | GBX15.03 Million ≈ $1.83K |
-11.21% |
| 2020-12-31 | GBX16.92 Million ≈ $2.06K |
+90.92% |
| 2019-12-31 | GBX8.86 Million ≈ $1.08K |
-3.85% |
| 2018-12-31 | GBX9.22 Million ≈ $1.12K |
-12.90% |
| 2017-12-31 | GBX10.59 Million ≈ $1.29K |
+35.79% |
| 2016-12-31 | GBX7.80 Million ≈ $948.54 |
+16.71% |
| 2015-12-31 | GBX6.68 Million ≈ $812.70 |
+4.35% |
| 2014-12-31 | GBX6.40 Million ≈ $778.85 |
-2.03% |
| 2013-12-31 | GBX6.53 Million ≈ $794.96 |
-14.06% |
| 2012-12-31 | GBX7.60 Million ≈ $925.02 |
-8.34% |
| 2011-12-31 | GBX8.29 Million ≈ $1.01K |
+0.18% |
| 2010-12-31 | GBX8.28 Million ≈ $1.01K |
-6.72% |
| 2009-12-31 | GBX8.88 Million ≈ $1.08K |
+3.64% |
| 2008-12-31 | GBX8.56 Million ≈ $1.04K |
-4.02% |
| 2007-12-31 | GBX8.92 Million ≈ $1.09K |
+17.63% |
| 2006-12-31 | GBX7.59 Million ≈ $922.90 |
-11.87% |
| 2005-12-31 | GBX8.61 Million ≈ $1.05K |
-14.77% |
| 2004-12-31 | GBX10.10 Million ≈ $1.23K |
-- |
About Eden Research plc
Eden Research plc, together with its subsidiaries, engages in the development and sale of biopesticides in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consume products, such a… Read more